載入...
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous group of chronic hematological malignancies characterized by dysplasia, ineffective hematopoiesis and a variable risk of progression to acute myeloid leukemia. Sequencing of MDS genomes has identified mutations in genes implicated in RNA splicing,...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3837510/ https://ncbi.nlm.nih.gov/pubmed/24030381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-08-518886 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|